Showing results (201-210 of 394) with videos related to
Sort By:
Pageof 40
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 2, 2011
Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosisC Tur, S Penny, Z Khaleeli, et al.Human Immunology|October 1, 1991
Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ?D A Francis, A J Thompson, P Brookes, et al.Hepatology International|July 8, 2011
Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosisJ Rowell, A J Thompson, J R Guyton, et al.Journal of Neurology|February 1, 1997
The transverse magnetisation decay characteristics of longstanding lesions and normal-appearing white matter in multiple sclerosisD Kidd, G J Barker, P S Tofts, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|February 13, 2003
Genetic analysis and FISH mapping of the Colourless non-ripening locus of tomatoM. Tör, K. Manning, G. J. King, et al.Marine Environmental Research|September 10, 2003
Contamination of organotin compounds and imposex in molluscs from Vancouver, CanadaT Horiguchi, Z Li, S Uno, et al.Brain : a Journal of Neurology|August 1, 2007
Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosisO Ciccarelli, C A Wheeler-Kingshott, M A McLean, et al.Neurology|January 11, 2008
Responsiveness and predictive value of EDSS and MSFC in primary progressive MSJ J Kragt, A J Thompson, X Montalban, et al.Brain : a Journal of Neurology|September 24, 2002
Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosisD T Chard, C M Griffin, M A McLean, et al.Journal of Neurology|August 14, 2001
Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosisG Giovannoni, D H Miller, N A Losseff, et al.Pageof 40